ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 108 filers reported holding ENZO BIOCHEM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $352,000 | -17.6% | 102,282 | -39.6% | 0.00% | -33.3% |
| Q4 2020 | $427,000 | +55.3% | 169,430 | +29.9% | 0.00% | -25.0% |
| Q3 2020 | $275,000 | +848.3% | 130,462 | +896.7% | 0.00% | – |
| Q2 2020 | $29,000 | -85.0% | 13,089 | -82.2% | 0.00% | -100.0% |
| Q4 2019 | $193,000 | -14.2% | 73,442 | +17.7% | 0.00% | -50.0% |
| Q3 2019 | $225,000 | -39.2% | 62,387 | -43.2% | 0.00% | -50.0% |
| Q2 2019 | $370,000 | -38.3% | 109,776 | -50.1% | 0.00% | -33.3% |
| Q1 2019 | $600,000 | +6.2% | 219,952 | +8.1% | 0.01% | -14.3% |
| Q4 2018 | $565,000 | -4.9% | 203,402 | +41.2% | 0.01% | 0.0% |
| Q3 2018 | $594,000 | +53.9% | 144,056 | +93.6% | 0.01% | +40.0% |
| Q2 2018 | $386,000 | +75.5% | 74,400 | +85.1% | 0.01% | +66.7% |
| Q1 2018 | $220,000 | -29.9% | 40,198 | +4.3% | 0.00% | -40.0% |
| Q4 2017 | $314,000 | -34.9% | 38,524 | -16.3% | 0.01% | -44.4% |
| Q3 2017 | $482,000 | +282.5% | 46,000 | +303.5% | 0.01% | +350.0% |
| Q2 2017 | $126,000 | +61.5% | 11,400 | +1.4% | 0.00% | -33.3% |
| Q4 2016 | $78,000 | – | 11,238 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
| Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
| Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
| CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
| Fondren Management LP | 175,863 | $593,000 | 0.56% |
| MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
| EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
| Leap Investments LP | 11,811 | $40,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |